Amy E. Du Beau
About
Amy E. Du Beau is a researcher with a substantial publication record spanning pharmacoepidemiology, maternal and child health, and chronic disease surveillance across European populations. Her work has appeared in journals including the European Journal of Epidemiology, JBMR Plus, and the Journal of Autism and Developmental Disorders, reflecting a breadth of methodological and clinical interests.
Much of her recent research has been conducted in the context of large-scale European collaborative projects. She has contributed to the ConcePTION project, an initiative examining drug safety in pregnancy and maternal health using electronic health records from multiple European countries. Her published work within that effort addresses the identification of conditions such as multiple sclerosis and attention deficit hyperactivity disorder in secondary healthcare data, as well as the prevalence of gabapentinoid prescriptions during pregnancy and antiretroviral drug exposure and congenital anomaly risk. Additional publications address topics including gut microbiome interventions and kidney function, fibroblast growth factor research in bone and muscle health, and dermatological access issues in Europe.
With 135 indexed publications, her research profile reflects sustained engagement with epidemiological methods applied to real-world healthcare data across diverse therapeutic areas.
Publications
- Therapeutic potential of FGF19 in combatting osteosarcopenia: effects on muscle strength and bone health in aged male mice.
- Mind the gap: Unequal access to hyaluronidase in Europe.
- The Effect of Different Algorithms on Prevalence of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder in Secondary Healthcare Data in Five European Countries: A Contribution from the ConcePTION Project.
- Methods of estimating prevalence of multiple sclerosis in six European healthcare data sources: a contribution from the ConcePTION project.
- Identifying multiple sclerosis in women of childbearing age in six European countries: a contribution from the ConcePTION project.
- A specifically designed multi-biotic reduces uremic toxin generation and improves kidney function.
- Identifying Maternal Conditions Leading to Gabapentinoid Prescriptions in Pregnancy Using Electronic Health Records from Six European Countries: A Contribution from the IMI ConcePTION Project.
- Antiretroviral drug exposure in pregnancy and risk of congenital anomalies: a European case/non-case malformed study.
- Adjusted trajectory of medication exposure taking into account the periodicity of dispensations and the number of dispensed packs and comparative analysis on EFEMERIS database.
- Risk of Congenital Ocular Anomaly After Prenatal Exposure to Medications: A EUROmediCAT Study.
Request CV and rates
Tell us about your case and we'll connect you with Amy E. Du Beau within two business days.
Other experts
Verified specialists available for your case.
